Recommandation pour la prise en charge d'une RTU
Traitement de la maladie de Takayasu répondant aux critères d’Ishikawa et résistant aux traitements conventionnels (corticoïdes et immunosuppresseurs
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
WDz7KUZFAWzQWsmw
